Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) — The report “Artificial Intelligence (AI) in Clinical Practice – Patient Perspective” has been added to ResearchAndMarkets.com’s offer.
The report examines the patient perspective on the use of artificial intelligence in healthcare settings in the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, Canada, India and Mexico.
Key takeaways from this report include:
- Younger patients were more confident that they understand artificial intelligence (AI) compared to older generations.
- Lack of personal interaction was the biggest patient concern associated with doctors using AI in clinical practice.
- Faster delivery of healthcare services and mitigation of healthcare workforce shortages were selected as the main benefits associated with the use of artificial intelligence in clinical practice.
- Patients who were familiar with AI were more confident that AI could improve patient care.
- Most patients felt more comfortable with doctors using artificial intelligence to automate administrative tasks compared to managing patient care.
- Patentees who were familiar with artificial intelligence were more comfortable visiting health care practices that used this technology.
- Doctors who had previous experience with artificial intelligence were more positive about patients being comfortable with the use of artificial intelligence to support clinical decisions.
- Implementing artificial intelligence can enhance patient monitoring technologies already used in healthcare.
Despite being a relatively new technology, artificial intelligence has been heralded as a key driver of future innovation in the healthcare sector. AI is poised to improve healthcare in several ways, including streamlining clinical workflow, addressing staff shortages, and improving patient diagnoses and treatment. While AI has enormous potential to disrupt clinical practice and is expected to become part of healthcare delivery processes, it is important to ensure that it is safe, ethical to use, and that both doctors and patients trust AI.
Scope
This report combines information obtained from secondary sources and primary research with patients suffering from conditions such as heart disease, diabetes, multiple sclerosis (MS), cancer, chronic respiratory conditions, rheumatoid arthritis (RA), psoriasis and inflammatory bowel disease (IBD). The patient survey was conducted between July-August 2023. The interviews and surveys with doctors and COPDs were conducted during March-June 2023.
Study goals
- Assess patients’ comfort level with physicians’ use of AI.
- Capture patient opinion on the use of artificial intelligence in clinical settings.
- Identify the processes in clinical practice that AI can improve the most.
- Explore the perceived advantages and disadvantages of AI.
- Compare the opinion of patients and doctors about the use of artificial intelligence.
Use Cases
- AI is tasked with identifying breast cancer
- AI helps organize electronic health records
- AI’s bid to tackle and ease NHS pressure
- Revolutionizing Public Health Management with Big Data and AI
- AI is proving useful in diabetes management
Reasons to buy
- This report combines information obtained from secondary sources and primary research with patients, health professionals, key opinion leaders (COLs) and physicians from various therapeutic areas.
- It assesses the current use of AI in clinical practice.
- Captures doctors’ and patients’ opinions about the use of AI.
- Identifies the processes in clinical practice that AI can improve the most – according to both patients and doctors.
- Explores patients’ comfort level with visiting healthcare practices that use AI.
- Includes AI case studies.
Key topics covered:
1 Summary
2 Study design
2.1 Dimensions and design
2.2 Respondent mix
2.3 Respondent profiles
3 Patient perception of AI
3.1 Patient knowledge level with AI
3.2 Patient concerns associated with HCPs using AI – by geography
3.3 Perceived benefits of artificial intelligence – by geography
3.4 Patients’ level of agreement with AI Improving Care
3.5 Patient level of agreement with AI that improves care – by geography
4 Patient comfort with AI
4.1 Patient comfort level with doctors using AI
4.2 Patient comfort level with doctors using AI – by geography
4.3 Patient comfort with visiting practices that use AI
4.4 Patient comfort with visiting practices using AI – by condition
5 Comfort with AI: Patients vs. Doctors
5.1 The doctor’s comfort level when using artificial intelligence
5.2 Doctor and patient comfort level when using artificial intelligence
5.3 The doctor’s comfort level when using artificial intelligence
6 Digital health, telemedicine and artificial intelligence
6.1 Patient use of digital and connected devices
6.2 Patient use of telemedicine
7 Use Cases
7.1 AI tasked with identifying breast cancer
7.2 AI helps organize electronic health records
7.3 AI’s bid for tackling and easing NHS pressure
7.4 Revolutionary public health management with Big Data and AI
7.5 AI proves useful in diabetes management
8 Summary of key findings
A selection of companies mentioned in this report include
- Brunei Ministry of Health
- Cedars-Sinai
- Dreamed
- Dyad
- EVIDENCE
- Lunit
- the national health service
- Teton.ai
- US Food and Drug Administration
- Vantage Health
For more information on this report visit https://www.researchandmarkets.com/r/az8tgk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and the latest trends.
